Application and development of Organ-on-a-Chip technology in cancer therapy
{{output}}
Cancer therapies are limited by tumor heterogeneity, complex tumor microenvironments (TME), and treatment resistance. Traditional 2D cell cultures cannot replicate tumor 3D architecture and dynamic interactions, reducing clinical relevance. Organoid-on-a-Chip ... ...
